Congratulations to the South Australian Health and Medical Research Institute (SAHMRI) for commencing screening participants for clinical trials as part of the ADNeT trial screening program.

Adelaide now joins Melbourne and Perth as active sites in this program, with Sydney and Brisbane expected to follow soon.

Doctors are able to refer patients they suspect of dementia/ mild cognitive impairment to the screening program for a detailed assessment. The referring doctor receives a full report.

For more information, contact Dr Jo Robertson, our national ADNeT Screening and Trials coordinator, at jo.robertson@unimelb.edu.au or 0408 508 121